Scarica l'app Stockscreener
4.86
3.19%
-0.16
Dopo l'orario di chiusura:
4.78
-0.08
-1.65%
Purple Biotech Ltd Adr Borsa (PPBT) Ultime notizie
Purple Biotech Ltd. Sponsored ADR Cash Flow – MUN:1YI0 - TradingView
Total liabilities & shareholders' equities of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
PPBT Earnings History & Surprises | EPS & Revenue Results | PURPLE BIOTECH LTD-ADR (NASDAQ:PPBT) - ChartMill
Purple Biotech Ltd. Sponsored ADR Balance Sheet – MUN:1YI0 - TradingView
Equity in earnings of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
Total debt per share of Purple Biotech Ltd. Sponsored ADR – MUN:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Statistics – MUN:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Income Statement – MUN:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Earnings and Revenue – MUN:1YI0 - TradingView
Purple Biotech Ltd. Sponsored ADR Financial Statements – MUN:1YI0 - TradingView
Purple Biotech (PPBT) to Release Quarterly Earnings on Monday - Defense World
Purple Biotech Stock Scheduled to Reverse Split on Monday, March 2nd (NASDAQ:PPBT) - Defense World
Purple Biotech Announces Plan to Implement ADS Ratio Change - ChartMill
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
Infrastructure Stocks Worth Watching – February 16th - Defense World
EverQuote, Inc. (NASDAQ:EVER) Short Interest Up 30.2% in January - Defense World
Short Interest in Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT) Expands By 29.9% - Defense World
Purple Biotech (NASDAQ:PPBT) Shares to Reverse Split on Monday, March 2nd - Defense World
Purple Biotech Ltd. (PPBT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewswire Inc.
Purple Biotech (NASDAQ:PPBT) Downgraded by Wall Street Zen to Strong Sell - Defense World
Taking on analysts’ expectations and winning: Purple Biotech Ltd ADR (PPBT) - Setenews
Q3 EPS Estimates for Purple Biotech Cut by HC Wainwright - Defense World
A new trading data show nLIGHT Inc (LASR) is showing positive returns. - Setenews
Purple Biotech (PPBT) to Release Quarterly Earnings on Friday - Defense World
An analyst sees good growth prospects for Purple Biotech Ltd ADR (PPBT) - Setenews
So-Young International Inc ADR (SY) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Purple Biotech stock soars after manufacturing milestone for tri-specific antibody By Investing.com - Investing.com South Africa
Purple Biotech stock soars after manufacturing milestone for tri-specific antibody - Investing.com
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results - Benzinga
Is Banco Santander S.A. Sponsored ADR stock a top dividend aristocrat candidateEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
Purple Biotech Enters New ATM Agreement with H.C. Wainwright - The Globe and Mail
Purple Biotech Ltd. enters $2.3M ATM - Investing.com
Purple Biotech (NASDAQ:PPBT) Trading Down 12.3% – Here’s Why - Defense World
Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference - Stock Titan
Purple Biotech (NASDAQ:PPBT) Trading Down 4.9% Following Weak Earnings - Defense World
Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025 - TipRanks
Purple Biotech (PPBT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
H.C. Wainwright lifts Purple Biotech stock target to $34 - Investing.com
Purple Biotech appoints Shai Lankry as new CFO - Investing.com
Best upcoming stock splits and reverse splits 2024 - Investorsobserver
PPBT Stock Price and Chart — NASDAQ:PPBT - TradingView — Track All Markets
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Nasdaq
Purple Biotech Ltd Share Price ADR Each Representing 200 Ord Shares SPON - Hargreaves Lansdown
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Why Purple Biotech (PPBT) Shares Are Trading Lower - Benzinga
Which stocks are moving before the opening bell on Thursday? - ChartMill
PPBT Ownership | PURPLE BIOTECH LTD-ADR (NASDAQ:PPBT) - ChartMill
Purple Biotech (PPBT) Stock Forecast and Price Target 2026 - MarketBeat
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Psyence Biomedical (PBM) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
60 Degrees Pharmaceuticals (SXTP) Short Interest & Short Float | Updated Jan 2026 - MarketBeat
CDT Equity (CDT) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
CANF Stock Quote Price and Forecast - CNN
Tickers - Finansavisen
Biodexa Pharmaceuticals (BDRX) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
Purple Biotech LtdADR (PPBT) News, Articles, Events & Latest Updates - Stocktwits
What is the current Price Target and Forecast for Purple Biotech (PPBT) - Zacks Investment Research
Purple Biotech Stock: Should I invest? - Value The Markets
PPBT Stock Price and Chart — TASE:PPBT - TradingView
Akanda (AKAN) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Indaptus Therapeutics (INDP) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
HCW Biologics (HCWB) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):